Viatris, Inc. (MYL)

0.00
NASDAQ
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 12.94 / 18.86
Exchange NASDAQ
Shares Outstanding 1209.29B
Div & Yield N.A. (N.A)

A Healthy Investment Idea

The health sector is one the less-beaten-down areas amid market weakness.

Mylan upgraded at Leerink

Mylan upgraded at Canaccord

Boring Is Beautiful

Boring Is Beautiful

Here are two generic-drug companies that should hold up well, regardless of the current uncertainty.

It's Just Healthy Profit-Taking

It's Just Healthy Profit-Taking

There's no reason to read much into it.

Watch Mylan

Watch Mylan

The generic drugmaker may be preparing to break from a key short-term channel pattern.

A Pair of Healthy Generic Drug Makers

A Pair of Healthy Generic Drug Makers

Secular trends appear likely to favor Mylan and Teva Pharmaceuticals.

MYL Investor Mtg.

Morgan Stanley Defending Mylan

Break in! Morgan Stanley (MS) is defending Mylan (MYL) now.

MYL Investor Mtg.

Mylan estimates raised at Citigroup

Mylan, Teva Break Through

Mylan, Teva Break Through

These two pharmaceuticals are standouts as the sector outperforms today.